Literature DB >> 24107762

Prediction of suicidal behavior in clinical research by lifetime suicidal ideation and behavior ascertained by the electronic Columbia-Suicide Severity Rating Scale.

James C Mundt1, John H Greist, James W Jefferson, Michael Federico, J John Mann, Kelly Posner.   

Abstract

OBJECTIVE: To evaluate whether lifetime suicidal ideation with intention to act and/or suicidal behaviors reported at baseline predict risk of prospectively reporting suicidal behavior during subsequent study participation.
METHOD: Data from studies using the electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) to prospectively monitor suicidal ideation and behaviors between September 2009 and May 2011 were analyzed. Studies included patients with major depressive disorder, insomnia, posttraumatic stress disorder, epilepsy, and fibromyalgia. Records for 35,224 eC-SSRS assessments were extracted. Incomplete assessments and eC-SSRS records from patients missing a baseline assessment or with no prospective follow-up assessments were excluded. Baseline lifetime eC-SSRS reports were categorized as negative (no lifetime ideation with intent to act or prior suicidal behavior) or positive (lifetime ideation with intent to act but no prior behavior, no ideation with intent to act but prior behavior, or both lifetime ideation with intent and prior behavior).
RESULTS: 3,776 patients completed a baseline and 1 or more follow-up assessments. The mean follow-up period was 64 days. Of patients with negative lifetime reports, 2.4% subsequently reported suicidal behavior during study participation, compared to 12.0% of patients with lifetime ideation with intent only (OR = 5.55; 95% CI, 2.65-11.59), 9.6% of patients with lifetime behavior only (OR = 4.33; 95% CI, 2.94-6.39), and 18.3% of patients with both (OR = 9.13; 95% CI, 6.47-12.88). Sensitivity and specificity of positive reports for identifying suicidal behaviors were 0.67 and 0.76, respectively.
CONCLUSIONS: Patients reporting lifetime suicidal ideation with intent to act and/or prior suicidal behavior at baseline are 4 to 9 times more likely to prospectively report suicidal behavior during study participation. © Copyright 2013 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 24107762     DOI: 10.4088/JCP.13m08398

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  33 in total

1.  Suicide risk and associated demographic and clinical correlates among primary care patients with recent drug use.

Authors:  Adam Carmel; Richard Ries; Imara I West; Kristin Bumgardner; Peter Roy-Byrne
Journal:  Am J Drug Alcohol Abuse       Date:  2016-02-24       Impact factor: 3.829

Review 2.  Emergency Department Screening for Suicide and Mental Health Risk.

Authors:  Kalina Babeva; Jennifer L Hughes; Joan Asarnow
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

Review 3.  Suicide Risk Assessment and Prevention: Challenges and Opportunities.

Authors:  Eileen P Ryan; Maria A Oquendo
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

Review 4.  Recommendations for evaluation of neurogenic bladder and bowel dysfunction after spinal cord injury and/or disease.

Authors:  Denise G Tate; Tracey Wheeler; Giulia I Lane; Martin Forchheimer; Kim D Anderson; Fin Biering-Sorensen; Anne P Cameron; Bruno Gallo Santacruz; Lyn B Jakeman; Michael J Kennelly; Steve Kirshblum; Andrei Krassioukov; Klaus Krogh; M J Mulcahey; Vanessa K Noonan; Gianna M Rodriguez; Ann M Spungen; David Tulsky; Marcel W Post
Journal:  J Spinal Cord Med       Date:  2020-03       Impact factor: 1.985

5.  Calculated Decisions: Columbia-Suicide Severity Rating Scale (C-SSRS)

Authors:  Joshua Salvi
Journal:  Emerg Med Pract       Date:  2019-05-01

6.  Predictive Value of Baseline Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) Assessments for Identifying Risk of Prospective Reports of Suicidal Behavior During Research Participation.

Authors:  John H Greist; James C Mundt; Chad J Gwaltney; James W Jefferson; Kelly Posner
Journal:  Innov Clin Neurosci       Date:  2014-09

7.  Prospective assessment of suicidal ideation and behavior: an internet survey of pharmaceutical sponsor practices.

Authors:  Phillip B Chappell; Atul R Mahableshwarkar; Larry D Alphs; Mark E Bangs; Adam Butler; Sarah J DuBrava; John H Greist; William R Lenderking; James C Mundt; Michelle Stewart
Journal:  Innov Clin Neurosci       Date:  2014-09

8.  Towards the objective assessment of suicidal states: Some neurocognitive deficits may be temporally related to suicide attempt.

Authors:  Alejandro Interian; Catherine E Myers; Megan S Chesin; Anna Kline; Lauren St Hill; Arlene R King; Rachael Miller; Miriam Latorre; Michael A Gara; Barbara H Stanley; John G Keilp
Journal:  Psychiatry Res       Date:  2019-10-18       Impact factor: 3.222

9.  Self-Reported Suicidal Ideation as a Predictor of Suicidal Behavior Among Outpatients With Diagnoses of Psychotic Disorders.

Authors:  Gregory E Simon; Bobbi Jo Yarborough; Rebecca C Rossom; Jean M Lawrence; Frances L Lynch; Beth E Waitzfelder; Brian K Ahmedani; Susan M Shortreed
Journal:  Psychiatr Serv       Date:  2018-12-10       Impact factor: 3.084

Review 10.  Psychiatric Emergencies: Assessing and Managing Suicidal Ideation.

Authors:  Andrea N Weber; Maria Michail; Alex Thompson; Jess G Fiedorowicz
Journal:  Med Clin North Am       Date:  2017-03-08       Impact factor: 5.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.